Impact of a Depression-Specific Pharmaceutical Care Counselingand Smartphone App in Medication Adherence among Patientswith Major Depressive Disorders: A pilot study

Main Article Content

Kotchakorn Nianmongkon https://orcid.org/0000-0003-1339-1330
Tanaporn Samphao https://orcid.org/0000-0001-5112-1863
Panpachara Nuchchom
Jannapas Tharavichitkun https://orcid.org/0000-0001-8074-5974
Rewadee Jenraumjit https://orcid.org/0000-0003-4534-8046

Keywords

Adherence, Medication, Pharmaceutical intervention, Counseling, Smartphone, Depression, clinical pharmacist

Abstract

Introduction: Medication nonadherence has a number of clinical consequences, including an increased risk of relapse and recurrence. By offering individualized in-person pharmaceutical care counseling, pharmacists play a significant part in encouraging medication adherence. One of the most popular forms of communication in nowadays is the smartphone. As a result, one of the measures for enhancing patients’ outcomes should be a smartphone app specifically designed for depression. Objectives: To investigate whether depression-specific counseling and smartphone app could improve medication adherence in newly diagnosed MDD patients. Methods: A prospective, randomized, pilot study was conducted in newly diagnosed major depressive disorder patients. They were randomly assigned to either the intervention or usual care groups (1:1). The intervention included in-person pharmaceutical care counseling along with the introduction use of a depression-specific smartphone app, whereas the usual care group received traditional pharmaceutical care counseling and simple chatbot. The primary outcome, medication adherence was measured using the Medication Adherence Rating Scale (MARS) and the percentage of pills counted (PC) at the one-month follow-up. The Patient Health Questionnaire-9 (PHQ-9) was used to assess depressive symptoms as a secondary outcome. Results: The study was completed by 36 participants (18 intervention and 18 usual care). The average age was 29.81 years, and 65.38% of the participants were female. The two groups had similar baseline characteristics, including baseline PHQ-9 scores. The intervention group had a mean MARS score of 7.0 (IQR=5) higher than the usual group, which had a mean score of 4.5 (IQR=7; p-value=0.04). The intervention group had a higher PC percentage of 81.75 (IQR=33.33) more than the usual care group, which had a mean percentage of 69.95 (IQR=78.57; p-value=0.10). The mean difference of PHQ-9 scores between two visits for the intervention and usual groups was -1.44 [-2.61 - -0.28]. (p-value=0.02). Discussion and Conclusions: This study discovered that new patients with major depression who received depression-specific pharmaceutical care counseling along with smartphone app improved their medication adherence. In addition, improvement in overall depression symptoms was discovered.

Abstract 557 | PDF Downloads 171

References

1. World Health Organization. Depression [Internet]. 2020 [cited 2022 SEP 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
2. Castrén E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant. Biol Psychiatry.2021;90(2):128-136. https://doi.org/10.1016/j.biopsych.2021.05.008
3. Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 ClinicalGuidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can JPsychiatry. 2016;61(9):540-60. https://doi.org/10.1177/0706743716659417
4. Hunot VM, Horne R, Leese MN, et al. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91-9. https://doi.org/10.4088/pcc.v09n0202
5. Semahegn A, Torpey K, Manu A, et al. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev.2020 16;9(1):17. https://doi.org/10.1186/s13643-020-1274-3
6. Ho SC, Chong HY, Chaiyakunapruk N, et al. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 2016;193:1-10. https://doi.org/10.1016/j.jad.2015.12.029
7. Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC psychiatry. 2012;12(1):87. https://doi.org/10.1186/1471-244X-12-87
8. Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387-97. https://doi.org/10.1111/ijpp.12462
9. Bunchuailua W, Samprasit N, Kotirum S, et al. Impact of pharmacist activities in patients with depression: a systematic review and meta-analysis of randomized controlled trials. Ann Pharmacother. 2022;56(5):556-64. https://doi. org/10.1177/10600280211041274
10. Readdean KC, Heuer AJ, Parrott JS. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis. Res Social Adm Pharm. 2018;14(4):321-31. https://doi.org/10.1016/j.sapharm.2017.05.008
11. Horvath T, Azman H, Kennedy GE, et al. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756. https://doi.org/10.1002/14651858.CD009756
12. Miralles I, Granell C, Díaz-Sanahuja L, et al. Smartphone apps for the treatment of mental disorders: systematic review. JMIR MHealth Uhealth. 2020;8(4):e14897. https://doi.org/10.2196/14897
13. Rathbone AL, Prescott J. The use of mobile apps and SMS messaging as physical and mental health interventions: systematic review. J Med Internet Res. 2017;19(8):e295. https://doi.org/10.2196/jmir.7740
14. Serrano-Ripoll MJ, Zamanillo-Campos R, Fiol-DeRoque MA. Impact of smartphone app–based psychological interventions for reducing depressive symptoms in people with depression: systematic literature review and meta-analysis of randomized controlled trials. JMIR Mhealth Uhealth 2022;10(1):e29621. https://doi.org/10.2196/29621 
15. Shariful Islam SM, Niessen LW, Ferrari U, et al. Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial. Diabetes Care. 2015;38(8):e112-3. https://doi.org/10.2337/dc15-0505
16. Chi BH, Stringer JS. Mobile phones to improve HIV treatment adherence. Lancet. 2010;376(9755):1807-8. https://doi.org/10.1016/S0140-6736(10)62046-6
17. Greer JA, Jacobs JM, Pensak N, et al. Randomized trial of a smartphone mobile app to improve symptoms and adherence to oral therapy for cancer. J Natl Compr Canc Netw. 2020;18(2):133-41. https://doi.org/10.6004/jnccn.2019.7354
18. Murdy KR, Glazer KL, Van Wert MJ, et al. Mobile technology for medication adherence in people with mood disorders: A systematic review. J Affect Disord. 2018;227:613-17. https://doi.org/10.1016/j.jad.2017.11.022
19. Moore DJ, Poquette A, Casaletto KB. et al. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015;19(3):459-71. https://doi.org/10.1007/s10461-014-0971-0
20. Thompson K,Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241-7. https://doi.org/10.1016/s0920-9964(99)00130-9
21. Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8:46-52.https://doi.org/10.1186/1471-244x-8-46
22. Olfson M, Marcus SC, Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States.
Am J Psychiatry. 2006;163(1):101-8. https://doi.org/10.1176/appi.ajp.163.1.101 23. Mitchell AJ. High Medication Discontinuation Rates in Psychiatry: How Often Is It Understandable. J Clin Psychopharmacol.2006;26(2):109-12. https://doi.org/10.1097/01.jcp.0000205845.36042.ba
24. s Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288(11):1403-9. https://doi.org/10.1001/jama.288.11.1403
25. Angermeyer MC, Löffler W, Müller P, et al. Patients’ and relatives’ assessment of clozapine treatment. Psychol Med.2001;31(3):509-17. https://doi.org/10.1001/jama.288.11.1403
26. Zhuang Q, Chen F, Wang T. Effectiveness of short message service intervention to improve glycated hemoglobin control and medication adherence in type-2 diabetes: a meta-analysis of prospective studies. Prim Care Diabetes. 2020;14(4):356-63.https://doi.org/10.1016/j.pcd.2019.09.007
27. Linardon J, Tyszkiewicz MF. Attrition and adherence in smartphone-delivered interventions for mental health problems: a systematic and meta-analytic review. J Consult Clin Psychol. 2020;88(1):1-13. https://doi.org/10.1037/ccp0000459